nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.725	1	CbGbCtD
Diphenhydramine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0164	0.0762	CcSEcCtD
Diphenhydramine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0489	CcSEcCtD
Diphenhydramine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0101	0.047	CcSEcCtD
Diphenhydramine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00887	0.0413	CcSEcCtD
Diphenhydramine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00843	0.0392	CcSEcCtD
Diphenhydramine—Captodiame—SIGMAR1—amyotrophic lateral sclerosis	0.00729	0.289	CrCbGaD
Diphenhydramine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00717	0.0334	CcSEcCtD
Diphenhydramine—Naftifine—SIGMAR1—amyotrophic lateral sclerosis	0.00714	0.283	CrCbGaD
Diphenhydramine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00708	0.033	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.007	0.0326	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0067	0.0312	CcSEcCtD
Diphenhydramine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0297	CcSEcCtD
Diphenhydramine—Chills—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0256	CcSEcCtD
Diphenhydramine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00524	0.0244	CcSEcCtD
Diphenhydramine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00519	0.0241	CcSEcCtD
Diphenhydramine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.005	0.0233	CcSEcCtD
Diphenhydramine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00491	0.0228	CcSEcCtD
Diphenhydramine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0048	0.0223	CcSEcCtD
Diphenhydramine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00472	0.022	CcSEcCtD
Diphenhydramine—Clomifene—SIGMAR1—amyotrophic lateral sclerosis	0.0047	0.186	CrCbGaD
Diphenhydramine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0215	CcSEcCtD
Diphenhydramine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00445	0.0207	CcSEcCtD
Diphenhydramine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00439	0.0205	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00427	0.0199	CcSEcCtD
Diphenhydramine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0198	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00421	0.0196	CcSEcCtD
Diphenhydramine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00415	0.0193	CcSEcCtD
Diphenhydramine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00407	0.019	CcSEcCtD
Diphenhydramine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0183	CcSEcCtD
Diphenhydramine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0182	CcSEcCtD
Diphenhydramine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00387	0.018	CcSEcCtD
Diphenhydramine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.0179	CcSEcCtD
Diphenhydramine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00379	0.0176	CcSEcCtD
Diphenhydramine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0175	CcSEcCtD
Diphenhydramine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00373	0.0173	CcSEcCtD
Diphenhydramine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0167	CcSEcCtD
Diphenhydramine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00346	0.0161	CcSEcCtD
Diphenhydramine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0146	CcSEcCtD
Diphenhydramine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00298	0.0139	CcSEcCtD
Diphenhydramine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0134	CcSEcCtD
Diphenhydramine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0129	CcSEcCtD
Diphenhydramine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0128	CcSEcCtD
Diphenhydramine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0128	CcSEcCtD
Diphenhydramine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0127	CcSEcCtD
Diphenhydramine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0121	CcSEcCtD
Diphenhydramine—Tamoxifen—SIGMAR1—amyotrophic lateral sclerosis	0.00217	0.086	CrCbGaD
Diphenhydramine—Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.00167	0.0663	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—amyotrophic lateral sclerosis	0.000919	0.0364	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—amyotrophic lateral sclerosis	0.000759	0.0301	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—amyotrophic lateral sclerosis	0.000607	0.024	CrCbGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000136	0.00386	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000136	0.00384	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000135	0.00383	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00013	0.00369	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000129	0.00365	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000129	0.00365	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000126	0.00358	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000126	0.00358	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000126	0.00358	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000126	0.00357	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000125	0.00354	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000123	0.00349	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000121	0.00344	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000118	0.00335	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000118	0.00335	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000118	0.00334	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000115	0.00327	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000115	0.00325	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000109	0.0031	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000107	0.00305	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000107	0.00304	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000107	0.00302	CbGpPWpGaD
Diphenhydramine—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000106	0.00301	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000105	0.00299	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000105	0.00298	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000101	0.00286	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.0001	0.00284	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	9.71e-05	0.00275	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.63e-05	0.00273	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.6e-05	0.00272	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	9.4e-05	0.00266	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—DAO—amyotrophic lateral sclerosis	9.13e-05	0.00259	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.96e-05	0.00254	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.78e-05	0.00249	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.74e-05	0.00248	CbGpPWpGaD
Diphenhydramine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.52e-05	0.00241	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.42e-05	0.00239	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.38e-05	0.00238	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.38e-05	0.00238	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	8.32e-05	0.00236	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.21e-05	0.00233	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	8.18e-05	0.00232	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.17e-05	0.00231	CbGpPWpGaD
Diphenhydramine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	8.15e-05	0.00231	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.14e-05	0.00231	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	8.14e-05	0.00231	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	8.14e-05	0.00231	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.1e-05	0.0023	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.99e-05	0.00226	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.81e-05	0.00221	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.81e-05	0.00221	CbGpPWpGaD
Diphenhydramine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.77e-05	0.0022	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.68e-05	0.00218	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.67e-05	0.00217	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.59e-05	0.00215	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.51e-05	0.00213	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.44e-05	0.00211	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.43e-05	0.00211	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.43e-05	0.00211	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	7.14e-05	0.00202	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.13e-05	0.00202	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	7.1e-05	0.00201	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.98e-05	0.00198	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.93e-05	0.00196	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.93e-05	0.00196	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.92e-05	0.00196	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	6.92e-05	0.00196	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.7e-05	0.0019	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.64e-05	0.00188	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.64e-05	0.00188	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.62e-05	0.00188	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.56e-05	0.00186	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.5e-05	0.00184	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	6.38e-05	0.00181	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.24e-05	0.00177	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.21e-05	0.00176	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.21e-05	0.00176	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.17e-05	0.00175	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.12e-05	0.00173	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.06e-05	0.00172	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.04e-05	0.00171	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	5.9e-05	0.00167	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	5.88e-05	0.00167	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.77e-05	0.00164	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	5.68e-05	0.00161	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	5.65e-05	0.0016	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.63e-05	0.0016	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	5.59e-05	0.00158	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.58e-05	0.00158	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.55e-05	0.00157	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.5e-05	0.00156	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.28e-05	0.0015	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.26e-05	0.00149	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	5.24e-05	0.00149	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.96e-05	0.00141	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	4.85e-05	0.00137	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.77e-05	0.00135	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	4.77e-05	0.00135	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.7e-05	0.00133	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	4.7e-05	0.00133	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	4.69e-05	0.00133	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	4.69e-05	0.00133	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	4.69e-05	0.00133	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	4.62e-05	0.00131	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.59e-05	0.0013	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.5e-05	0.00127	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	4.49e-05	0.00127	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.46e-05	0.00126	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.37e-05	0.00124	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	4.31e-05	0.00122	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	4.31e-05	0.00122	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	4.29e-05	0.00122	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.28e-05	0.00121	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.28e-05	0.00121	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.28e-05	0.00121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	4.27e-05	0.00121	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.24e-05	0.0012	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	4.2e-05	0.00119	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	4.11e-05	0.00117	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	4.11e-05	0.00117	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.99e-05	0.00113	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.99e-05	0.00113	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	3.95e-05	0.00112	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.95e-05	0.00112	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	3.91e-05	0.00111	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	3.75e-05	0.00106	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.75e-05	0.00106	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.67e-05	0.00104	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.65e-05	0.00104	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.65e-05	0.00104	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.64e-05	0.00103	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.63e-05	0.00103	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	3.57e-05	0.00101	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.48e-05	0.000986	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.45e-05	0.000978	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.42e-05	0.000969	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.41e-05	0.000966	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.4e-05	0.000964	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	3.39e-05	0.000961	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.38e-05	0.000957	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.34e-05	0.000947	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.33e-05	0.000943	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	3.27e-05	0.000928	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.24e-05	0.000919	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	3.14e-05	0.00089	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.13e-05	0.000887	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	3.12e-05	0.000884	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.11e-05	0.000881	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.09e-05	0.000876	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.08e-05	0.000874	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.08e-05	0.000872	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.97e-05	0.00084	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.92e-05	0.000828	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.92e-05	0.000827	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.87e-05	0.000814	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.83e-05	0.000801	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.82e-05	0.000799	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.64e-05	0.000749	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.59e-05	0.000734	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.58e-05	0.000731	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.57e-05	0.000728	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.55e-05	0.000723	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.52e-05	0.000715	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.51e-05	0.000711	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.48e-05	0.000703	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.37e-05	0.000672	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.36e-05	0.00067	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.34e-05	0.000664	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	2.18e-05	0.000618	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.16e-05	0.000613	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.16e-05	0.000612	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	2.13e-05	0.000604	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.11e-05	0.000599	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.11e-05	0.000597	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000588	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.05e-05	0.000581	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.02e-05	0.000572	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2e-05	0.000568	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.97e-05	0.000558	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.95e-05	0.000552	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.87e-05	0.00053	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.86e-05	0.000528	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.85e-05	0.000524	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.83e-05	0.00052	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.82e-05	0.000515	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.79e-05	0.000508	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.78e-05	0.000504	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.78e-05	0.000503	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.74e-05	0.000494	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.73e-05	0.000491	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.72e-05	0.000487	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.7e-05	0.000483	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.68e-05	0.000477	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.67e-05	0.000473	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.62e-05	0.00046	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.62e-05	0.000459	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000454	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.6e-05	0.000453	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.55e-05	0.000439	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.52e-05	0.000432	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.00043	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.46e-05	0.000414	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.41e-05	0.000401	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.39e-05	0.000393	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.38e-05	0.000392	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	1.37e-05	0.000389	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.32e-05	0.000375	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000374	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.3e-05	0.000369	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.000361	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000353	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.000347	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.000345	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.11e-05	0.000315	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.1e-05	0.000312	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.08e-05	0.000307	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000297	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.05e-05	0.000297	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.02e-05	0.00029	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.01e-05	0.000286	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.69e-06	0.000275	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.63e-06	0.000273	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.62e-06	0.000273	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.55e-06	0.000271	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.49e-06	0.000269	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.41e-06	0.000267	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.03e-06	0.000256	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.85e-06	0.000251	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.77e-06	0.000249	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.47e-06	0.00024	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.33e-06	0.000236	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.16e-06	0.000231	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	7.92e-06	0.000224	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.5e-06	0.000212	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	7.28e-06	0.000206	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	7.22e-06	0.000205	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.18e-06	0.000203	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.52e-06	0.000185	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.41e-06	0.000182	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	6.17e-06	0.000175	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.16e-06	0.000175	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.06e-06	0.000172	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.53e-06	0.000157	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.44e-06	0.000154	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.42e-06	0.000154	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.99e-06	0.000141	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.95e-06	0.00014	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.23e-06	0.00012	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.18e-06	0.000118	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.11e-06	0.000117	CbGpPWpGaD
